Invention Grant
US08772313B2 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor
有权
适用于治疗对5-羟色胺5-HT 6受体调节作出反应的病症的苯磺酰基或磺酰胺化合物
- Patent Title: Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor
- Patent Title (中): 适用于治疗对5-羟色胺5-HT 6受体调节作出反应的病症的苯磺酰基或磺酰胺化合物
-
Application No.: US13286387Application Date: 2011-11-01
-
Publication No.: US08772313B2Publication Date: 2014-07-08
- Inventor: Andreas Haupt , Frauke Pohlki , Liliane Unger , Ana Lucia Relo , Karsten Wicke , Min Zhang
- Applicant: Andreas Haupt , Frauke Pohlki , Liliane Unger , Ana Lucia Relo , Karsten Wicke , Min Zhang
- Applicant Address: US IL Abbott Park DE Wiesbaden
- Assignee: Abbott Laboratories,AbbVie Deutschland GmbH & Co. KG
- Current Assignee: Abbott Laboratories,AbbVie Deutschland GmbH & Co. KG
- Current Assignee Address: US IL Abbott Park DE Wiesbaden
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: A61K31/435
- IPC: A61K31/435 ; A61K31/451 ; A61K31/40 ; A61K31/403 ; A61P3/04 ; A61P25/30 ; A61P25/28 ; A61P25/18 ; A61P25/00 ; C07D211/28 ; C07D209/52 ; C07D221/04
Abstract:
The present invention relates to benzenesulfonyl or sulfonamide compounds of formulae IA and IB wherein the variables have the meanings given in the claims and the description, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT6 receptor.
Public/Granted literature
Information query
